Compare Daicel Corp. with Similar Stocks
Stock DNA
Specialty Chemicals
JPY 338,483 Million (Mid Cap)
8.00
NA
0.00%
0.63
12.34%
0.88
Revenue and Profits:
Net Sales:
154,805 Million
(Quarterly Results - Mar 2026)
Net Profit:
-25,034 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.84%
0%
-0.84%
6 Months
-7.82%
0%
-7.82%
1 Year
10.91%
0%
10.91%
2 Years
-16.78%
0%
-16.78%
3 Years
1.93%
0%
1.93%
4 Years
54.9%
0%
54.9%
5 Years
44.38%
0%
44.38%
Daicel Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.70%
EBIT Growth (5y)
14.31%
EBIT to Interest (avg)
31.69
Debt to EBITDA (avg)
2.55
Net Debt to Equity (avg)
0.60
Sales to Capital Employed (avg)
0.86
Tax Ratio
22.93%
Dividend Payout Ratio
33.07%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.84%
ROE (avg)
14.03%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.98
EV to EBIT
12.33
EV to EBITDA
6.66
EV to Capital Employed
0.99
EV to Sales
1.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.01%
ROE (Latest)
12.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Jun 2020
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
154,805.00
147,705.00
4.81%
Operating Profit (PBDIT) excl Other Income
21,450.00
23,408.00
-8.36%
Interest
853.00
796.00
7.16%
Exceptional Items
-32,063.00
0.00
Consolidate Net Profit
-25,034.00
17,304.00
-244.67%
Operating Profit Margin (Excl OI)
62.20%
83.40%
-2.12%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 4.81% vs 7.15% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -244.67% vs 86.99% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
579,629.00
586,531.00
-1.18%
Operating Profit (PBDIT) excl Other Income
85,413.00
102,384.00
-16.58%
Interest
3,198.00
1,983.00
61.27%
Exceptional Items
-30,506.00
-8,385.00
-263.82%
Consolidate Net Profit
11,446.00
50,477.00
-77.32%
Operating Profit Margin (Excl OI)
72.60%
104.00%
-3.14%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is -1.18% vs 5.10% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -77.32% vs -10.73% in Mar 2025
About Daicel Corp. 
Daicel Corp.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






